RADx Tech DIVE Annoucement - POCTRN

The Point-of-Care Technology Research Network develops technologies with clinical applications using a network model that enhances complementary strengths and builds multidisciplinary partnerships.

LEARN MORE

2023 POCTRN awardees announced

Congratulations to the six Technology Research and Development Centers around the country that comprise the Point-of-Care Technology Research Network (POCTRN). Established in 2007 by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), POCTRN has facilitated a pipeline of technologies and expertise that address health conditions from heart disease to cancer to HIV/AIDS and that extends across domains from child health to global health.

Coordination among all the centers will continue to be led by CIMIT, who will reprise their role as the POCTRN Coordinating Center. Each center will use a milestone-driven approach to focus resources on the development of technologies that demonstrate the highest chance of success.

Learn more about each center below.

Atlanta Center for Microsystems Engineered Point-of-Care Technologies

Focus: To develop and translate microsystems-engineered technologies including microchip-enabled devices that include microelectromechanical systems (MEMs)-based sensors, microfluidics, and smartphone-based systems.

Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases

Focus: To develop and test the accuracy, acceptability, and optimal implementation of point-of-care tests for sexually transmitted diseases in diverse care delivery contexts both in the United States and in resource-limited settings.

Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern

Focus: To support the development of a pipeline of Point-of-Care Technologies designed to meet the clinical needs of people who live with HIV/AIDS and emerging infectious diseases in low- and middle-income countries.

Center for Advancing Point of Care in Heart, Lung, Blood, and Sleep Diseases

Focus: To support development and testing of promising “late-stage” point of care technologies that can be rapidly deployed to enhance the diagnosis, monitoring, management and/or treatment of heart, lung, blood and sleep disorders.

Center for Point of Care Technologies for Nutrition, Infection, and Cancer in Global Health at Cornell University

Focus: To support development, deployment, clinical validation, and commercialization of point-of-care technologies for nutrition, infection and cancer for global health in locations where access to better diagnostics can have the largest worldwide impact. We focus on technologies that address the primary needs of the most vulnerable in the US and internationally.

The Center for Innovation and Translation of Point of Care Technologies for Equitable Cancer Care

Focus: To accelerate the development and adoption of new technologies that can be used to improve the early detection of cancer in low-resource settings in the United States and globally.

Center news

null RADx Tech DIVE Annoucement

RADx Tech DIVE

Expanding diversity among healthcare innovators and biomedical engineers.

Do you have an innovative device, product, or technology currently in pursuit of funding or other technical resources? If so, apply to RADx® Tech DIVE. This unique fellowship program, supported by the NIBIB, will help you gain a clearer picture of your healthtech project's maturity, address key risks, and learn the next steps to secure funding.

24 fellows, and their teams, will be selected to join this educational program uniquely designed to support innovators from populations historically underrepresented in the biotech research space.

At the conclusion of the course, four fellows will be recognized with a prize of up to $7,500 to help support future endeavors.

The deadline has passed to apply for this opportunity.

POCTRN and COVID-19

In response to COVID-19 pandemic, POCTRN has helped to launch the Rapid Acceleration of Diagnostics (RADx) initiative to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19. We have also curated a number resources and additional funding opportunities on our resources page.